Securities Class Action V. Threshold Pared Down
A federal judge has tossed claims from an amended securities fraud class action against Threshold Pharmaceuticals Inc. and two of its top executives, almost a year after dismissing the shareholder plaintiffs'...To view the full article, register now.
Already a subscriber? Click here to view full article